GLOBAL IMAGING BRIEF
Why it matters
Digital pathology increasingly depends on interoperable image-management and AI workflows. Laboratories should verify validation status, intended use and regulatory constraints separately for each AI function.
Fujifilm announced Synapse Pathology v3.0 on October 12, describing more than 50 new functions and AI orchestration features for digital slide workflows. It also introduced a pathology-specific AI foundation-model initiative for Pathology Visions 2026; the announcement does not provide independent clinical-performance validation.
GLOBAL IMAGING BRIEF
Digital pathology increasingly depends on interoperable image-management and AI workflows. Laboratories should verify validation status, intended use and regulatory constraints separately for each AI function.
Original source
This brief is an original summary based on the cited public source.